News - Voraxaze

Filter

Current filters:

Voraxaze

Popular Filters

BTG’s Voraxaze gains first approval, in USA

19-01-2012

The US Food and Drug Administration has approved UK headquartered BTG International’s (LSE: BGC)…

BiotechnologyBTGNephrology and HepatologyNorth AmericaOncologyRegulationVoraxaze

Voraxaze out-licensed in Japan

07-12-2011

UK health care firm BTG (LSE: BGC) says that it has licensed the Japanese rights to glucarpidase (which…

Asia-PacificBTGglucarpidaseLicensingOhara PharmaceuticalOncologyPharmaceuticalVoraxaze

Back to top